Munehisa Yabuki

This inventor holds 15 USPTO granted patents and 10 published patent applications, plus 6 CIPO patents and 4 EPO patents. Top assignees: Omeros Corporation, University of Washington. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Munehisa Yabuki. Retrieved from https://idiyas.com/inventor/munehisa-yabuki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 10)

% Patents Active = 86.7

CIPO Patents = 6 (Patent Applications = 6)

EPO Patents = 4 (Patent Applications = 13)

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 32(Granted Patents)

Company Filing History:

University of Washington

patents

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12129290 - Monoclonal antibodies, compositions and methods for detecting complement factor D (2024-10-29),

2. 12091468 - Therapeutic antibodies that bind to the serine protease domain of MASP-2 and uses thereof (2024-09-17),

3. 11883493 - Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders (2024-01-30),

4. 11045544 - Methods of generating bioactive peptide-bearing antibodies and compositions comprising the same (2021-06-29),

5. 11027015 - Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders (2021-06-08),

6. 10745274 - Nucleic acids encoding antibodies specifically binding to MASP-3 (2020-08-18),

7. 10639369 - Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders (2020-05-05),

8. 9815885 - Inducible mutagenesis of target genes (2017-11-14),

9. 9777065 - Anti-FZD10 monoclonal antibodies and methods for their use (2017-10-03),

10. 9677070 - Composition and method for diversification of target sequences (2017-06-13),

11. 9346888 - Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolution (2016-05-24),

12. 9273119 - Inducible mutagenesis of target genes (2016-03-01),

13. 9102724 - Anti-FZD10 monoclonal antibodies and methods for their use (2015-08-11),

14. 8679845 - B cells modified to reversibly induce accelerated mutagenesis of target genes (2014-03-25),

15. 8609818 - Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolution (2013-12-17),

Title: Munehisa Yabuki: Pioneering Inventor from Seattle

Introduction: Munehisa Yabuki is a distinguished inventor based in Seattle, Washington, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Munehisa Yabuki holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating solutions for the future.

Career Highlights: With a career spanning over two decades, Yabuki has worked with leading tech companies in Seattle, driving innovation and pushing the boundaries of what is possible in the industry.

Collaborations: Throughout his career, Munehisa Yabuki has collaborated with top researchers, engineers, and scientists, fostering a culture of creativity and excellence in all his projects.

Conclusion: Munehisa Yabuki's passion for innovation and his relentless pursuit of technological advancement make him a true pioneer in the world of inventions, shaping the future of technology one patent at a time.

Profile summary based on public USPTO records.